(Press-News.org) Montreal, January 27, 2021 - Taking cannabidiol, a chemical in the cannabis sativa plant, isn't an effective way to reduce your dependence on cocaine, researchers at the CHUM Research Centre find.
In North America, close to 5.5 million people use cocaine regularly, and nearly one in five becomes addicted, developing cocaine use disorder, for which there is no clinical treatment. One solution has been touted, however: treatment with cannabidiol.
Better known as CBD, it's a chemical in the cannabis sativa plant known for its protective effects on the brain and liver. But there is very little scientific evidence to support its use as a treatment for addiction.
In fact, in a study published this month in the journal Addiction, a Canadian scientific team at the CHUM Research Centre (CRCHUM) shows that the therapeutic virtues of CBD are largely non-existent.
As a way to help coke addicts kick the habit, CBD simply doesn't work, according to the scientists, led by Université de Montréal psychiatry professor Didier Jutras-Aswad: it doesn't make addicts want cocaine less, nor does it reduce their risk of relapse into addiction.
78 addicts tested
In a clinical trial, Jutras-Aswad and his team recruited 78 coke addicts, average age 46, most of them with severe cocaine use disorder, and randomly divided the participants into two groups: one receiving cannabidiol (800 mg per day), the other a placebo.
Neither the participants nor the researchers knew which treatment was administered. Following 10 days in hospital to detox, the participants were sent home and for the next three months received weekly check-ups.
"In our study, the use of CBD was not more effective than a placebo in treating cocaine use disorder," said Violaine Mongeau-Pérusse, first author of the study and a PhD student in the Jutras-Aswad's lab.
"Although it is safe and produces only mild side effects, CBD reduces neither the craving to use cocaine nor the risk of a user's relapse after detoxification," she said.
More studies needed
Calling their results conclusive, the UdeM researchers hope their study will help orient medical guidelines on the therapeutic use of CBD, which has seen growing popularity in Canada and elsewhere in the world.
There are over 19 million cocaine users globally, according to recent estimates.
Other studies will be needed to continue to sort out the conditions under which CBD may be helpful or not, said Mongeau-Pérusse, but for now the evidence is in: if you want to beat your coke habit, cannabis isn't a good choice.
INFORMATION:
This research was supported by the Canadian Institutes of Health Research.
Further reading: "Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo controlled trial," by Violaine Mongeau-Pérusse et al., was published Jan. 19, 2021, in Addiction. DOI: 10.1111/add.15417
About the CRCHUM
The University of Montreal Hospital Research Centre (CRCHUM) is one of North America's leading hospital research centres. It strives to improve adult health through a research continuum covering such disciplines as the fundamental sciences, clinical research and public health. Over 1,850 people work at the CRCHUM, including more than 550 researchers and more than 460 graduate students. chumontreal.qc.ca/crchum @CRCHUM
About Université de Montréal
Deeply rooted in Montreal and dedicated to its international mission, Université de Montréal is one of the top universities in the French-speaking world. Founded in 1878, Université de Montréal today has 13 faculties and schools, and together with its two affiliated schools, HEC Montréal and Polytechnique Montréal, constitutes the largest centre of higher education and research in Québec and one of the major centres in North America. It brings together 2,400 professors and researchers and has more than 67,000 students. umontreal.ca
Stopping the spread of COVID-19 is difficult enough. It's even more complicated and confusing when information and resources provided by governments are largely inaccessible to a variety of disabled populations. A newly-published global survey of national health authority websites in nearly 200 countries has directly quantified COVID-19 information accessibility.
The survey, published on January 27, 2021 in the journal Frontiers in Medicine, was conducted by researchers and medical professionals from Bar-Ilan University's Azrieli Faculty of Medicine, the Galilee Medical Center and Tel Aviv ...
As the climate warms and Arctic sea ice retreats, research vessels and commercial ships are sailing into the Arctic Ocean more and more, but the accuracy and sensitivity of regional weather and marine forecasts for these hazardous waters still lag well behind those of their lower-latitude counterparts, with significant differences between regional models. Direct measurements of atmospheric conditions, such as cloud cover and solar radiation, can help to evaluate and improve these models.
In a new study published in the Journal of Geophysical Research: Atmospheres, a research team led by the National Institute of Polar Research in Tachikawa, ...
Sophia Antipolis, 27 January 2021: Pregnancy complications and early menopause increase women's future risk of heart disease. Cardiologists, gynaecologists and endocrinologists recommend how to help middle-aged women prevent later heart problems in a European Society of Cardiology (ESC) consensus document published today in European Heart Journal, a journal of the ESC.1
"Physicians should intensify the detection of hypertension in middle-aged women," states the document. Up to 50% of women develop high blood pressure before the age of 60 but the symptoms - for example hot flushes and palpitations - are often attributed ...
Researchers from Queen Mary University of London and Zhengzhou University have developed a powerful therapeutic platform that uses a modified virus for the treatment of pancreatic cancer. By using the virus in combination with other drugs, the treatment significantly extended survival in preclinical models of pancreatic cancer.
Viruses that can selectively infect and destroy cancer cells, known as oncolytic viruses, are a promising new class of therapeutics for cancer. Through various mechanisms, oncolytic viruses kill cancer cells and elicit strong anti-tumour immune responses. However, current oncolytic virotherapy is unable to produce a long-term cure in patients, and the treatment has to be delivered directly into the tumour - a route that is not feasible for deeply embedded ...
A material that can be used in technologies such as solar power has been found to self-heal, a new study shows.
The findings - from the University of York - raise the prospect that it may be possible to engineer high-performance self-healing materials which could reduce costs and improve scalability, researchers say.
The substance, called antimony selenide (Sb2Se3), is a solar absorber material that can be used for turning light energy into electricity.
Professor Keith McKenna from the Department of Physics said: "The process by which this semi-conducting material self-heals is rather like how a salamander is able to re-grow limbs when one is severed. Antimony selenide repairs broken bonds created when it is cleaved by ...
The disproportionately high Covid-19 infection rates observed in Black Americans could be linked to their daily commuting patterns, according to a new study published today in the Journal of the Royal Society Interface.
The research found that increased exposure to other ethnic groups, for example as a result of an individual's job or use of public transport, can result in the emergence of an "infection gap" in the population, such as the abnormally high incidence of Covid-19 recorded in Black Americans.
In some areas of the US Covid-19 incidence in Black Americans can be up to three to five times higher than would be expected based on population data. Previous studies have highlighted socio-economic factors including lower income and poorer access to healthcare facilities ...
Chronic myeloid leukemia (CML) results from a degeneration of the hematopoietic stem cells (leukemia stem cells), thereby leading to the uncontrolled formation of specific white blood cells, the so-called granulocytes. Research work at the Department of Medical Oncology at the Inselspital, Bern University Hospital and the University of Bern focused therefore on identifying the signaling pathways and control mechanisms of the leukemia stem cell. A promising approach is provided by working with MPR, an anti-emetic medication commonly used to treat nausea and vomiting.
Specific blocking of leukemia stem cell proliferation with metoclopramide
The exact role of the surface molecule CD93 (cluster of differentiation 93) in controlling the ...
A multidisciplinary team of researchers at the University of Massachusetts Amherst's Institute for Applied Life Sciences (IALS) have developed a technique to replicate bone tissue complexity and bone remodeling processes. This breakthrough could help researchers further their study of bone biology and assist in improving development of drugs for osteoporosis.
Published in Science Advances, the researchers developed a new biomaterial they call demineralized bone paper. The team includes Jungwoo Lee, Yongkuk Park, Ryan Carpenter, chemical engineering; Eugene Cheong, ...
Our cells are filled with 'bones,' in a sense. Thin, flexible protein strands called actin filaments help support and move around the bulk of the cells of eukaryotes, which includes all plants and animals. Always on the go, actin filaments constantly grow, shrink, bind with other things, and branch off when cells move.
Supercomputer simulations have helped solve the mystery of how actin filaments polymerize, or chain together. This fundamental research could be applied to treatments to stop cancer spread, develop self-healing materials, and more.
"The major findings ...
A compound that extends lifespan in a tiny nematode worm slows bone loss in aging mice. That surprising result comes from a longitudinal and functional study of 700 aging mice at the Buck Institute, a project that provides a treasure trove of data for researchers aiming to develop therapeutics to slow aging and age-related diseases. The study is currently online in the Journal of Bone and Mineral Research Plus.
The project, which involved five Buck labs and took several years to complete, involved serially profiling the individual mice as they aged while testing several therapeutics that extended lifespan in simple model organisms ...
